A potential strategy introduces an entirely new type of therapy capable of addressing previously ‘undruggable’ targets within the cells.

The development of novel therapeutics offers great hope for the fight against widespread diseases such as cancer, but they ...

These heart cells rupture and leak DNA, which sparks a damaging immune response. This breakthrough challenges long-held ...

Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on preventing heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) through ...

Malcolm Fairley, who became known as 'The Fox', carried out a series of sex attacks across Bedfordshire, Buckinghamshire and ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and ...

With mepolizumab vs. placebo, patients with COPD and type 2 inflammation experienced significantly fewer moderate/severe ...

Previous research has shown that the severity of heart damage after an acute myocardial infarction, or heart attack ... to ...

Mesoblast Limited’s MESO share price has dipped by 5.56%, which has investors questioning if this is right time to buy.

Amgen today announced financial results for the first quarter of 2025. "Demand for our products was strong globally in the first quarter. Ongoing new product launches and successful Phase 3 trial ...

Scientists have developed a powerful new injectable treatment that, when administered after a heart attack, helps the heart ...